NASDAQ: KYNB KYNTRA BIO, INC. 8-K

Kyntra Bio reports Q1 2026 financial results

Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read

Key Changes

  • medium

    Kyntra Bio issued a press release announcing financial results for the quarter ended March 31, 2026. Specific figures are contained in the attached press release (Exhibit 99.1), not in the 8-K body itself.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.

Partner

Trade KYNB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 10:25 PM